These findings thus nullify our initial hypothesis suggesting that if Malat1 expression declines with age, and if Malat1 were a regulatory node, a genetically-engineered deletion of Malat1 by itself should result in premature development of age-associated metabolic disorders. This evidence concerns the gene MALAT1 and metabolic disease.